Adderall

Sales & Marketing

Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.

News

Novartis has secured EU approval for Itvisma, a new formulation of its spinal muscular atrophy gene therapy usable in a broader patient population.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.